Vcanbio Cell & Gene Engineering Co., Ltd. (600645)
Market Closed
6 Aug, 06:57
SSE SSE Primary ¥
18. 87
-0.08
-0.4222%
¥
9.7B Market Cap
- P/E Ratio
0.02% Div Yield
11.7M Volume
- Eps
¥ 18.95
Previous Close Want to track 600645 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vcanbio Cell & Gene Engineering Co., Ltd. (600645) Statistics
Valuation metrics
Market Cap 9.7B
Enterprise value 7.03B
Trailing P/E (ttm) 79.43
Forward P/E -
PEG ratio 3.02
Price/Sales (ttm) 6.01
Price/Book (mrq) 2.45
Enterprise Value/Revenue 4.95
Enterprise Value/EBITDA 20.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.56M
Average volume (90 days) 11.04M
Price summary
52-Week low 16.24
52-Week high 32.99
Beta -
50-Day moving average 18.23
200-Day moving average 24.18
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 16:10
Last split Date 24 Jan 2007
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 1.88%
Book value per share (mrq) 7.77
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
